Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2018
An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid Leukemia
Bing Zheng, Shang-Fan Yu, Geoffrey Del Rosario, et al.
Cancer Cell
|
January 16, 2007
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth
Qi Pan, Yvan Chanthery, Wei-Ching Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy
Irene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Amy A Lo, Jennifer Johnston, Ji Li, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Yonglei Shang, Yifan Mao, Jennifer Batson, et al.
Cancer Cell
|
April 9, 2008
Blocking neuropilin-2 function inhibits tumor cell metastasis
Maresa Caunt, Judy Mak, Wei-Ching Liang, et al.
Molecular Pharmaceutics
|
April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer
Steven R Leong, Wei-Ching Liang, Yan Wu, et al.
Immunity
|
February 13, 2020
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
Yi Zhou, Mingjian Fei, Gu Zhang, et al.
Science Advances
|
May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicity
Yvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Science Translational Medicine
|
August 5, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Tianhe Sun, Zhiyu Huang, Wei-Ching Liang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2018
An Anti-CLL-1 Antibody-Drug Conjugate for the Treatment of Acute Myeloid Leukemia
Bing Zheng, Shang-Fan Yu, Geoffrey Del Rosario, et al.
Cancer Cell
|
January 16, 2007
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth
Qi Pan, Yvan Chanthery, Wei-Ching Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 30, 2020
Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy
Irene Tom, Victoria C Pham, Kenneth J Katschke, et al.
Molecular Cancer Therapeutics
|
February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Amy A Lo, Jennifer Johnston, Ji Li, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Yonglei Shang, Yifan Mao, Jennifer Batson, et al.
Cancer Cell
|
April 9, 2008
Blocking neuropilin-2 function inhibits tumor cell metastasis
Maresa Caunt, Judy Mak, Wei-Ching Liang, et al.
Molecular Pharmaceutics
|
April 9, 2015
An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer
Steven R Leong, Wei-Ching Liang, Yan Wu, et al.
Immunity
|
February 13, 2020
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP
Yi Zhou, Mingjian Fei, Gu Zhang, et al.
Science Advances
|
May 22, 2026
Tumor-targeted bispecific antibodies effectively inhibit oncogenic pathways while minimizing toxicity
Yvonne T Kschonsak, Wei-Ching Liang, Joyce Chan, et al.
Science Translational Medicine
|
August 5, 2021
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Tianhe Sun, Zhiyu Huang, Wei-Ching Liang, et al.
Page
of 5